Position in TMO
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$18,048
+$353 QoQ
Shares Held
36
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,498
of 2,602 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Clark Wealth Partners holds $45,611 across 10 Diagnostics & Research names. TMO ranks #1 (39.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
36 | $18,048 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
12 | $6,317 | |
| 3 | DHR |
Danaher Corp /De/
|
31 | $5,904 | |
| 4 | A |
Agilent Technologies, Inc.
|
31 | $4,117 | |
| 5 | DGX |
Quest Diagnostics Inc
|
17 | $3,603 | |
| 6 | WAT |
Waters Corp /De/
|
8 | $3,000 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
8 | $1,545 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1 | $1,277 |
All Filings in TMO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,048 | 36 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $17,695 | 36 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $29,551 | 51 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $24,736 | 51 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $7,703 | 19 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $9,454 | 19 | Shares | Sole | 2026-02-04 | |
| 2024-12-31 | $9,884 | 19 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||